Trials / Completed
CompletedNCT00420563
Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer
A Phase II Randomized Study to Assess the Benefit of a Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Centre Oscar Lambret · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The scope of the trial is to assess the free progression rate at 2 months for each group of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CYCLOPHOSPHAMIDE | 50 mg x 2 /day , per os, nonstop until disease progression or toxicity or patient decision |
| DRUG | MEGESTROL | 320 mg/day, per os, 2 pills of 160 mg one time, nonstop until disease progression or toxicity or patient decision |
Timeline
- Start date
- 2009-09-25
- Primary completion
- 2011-01-19
- Completion
- 2011-01-19
- First posted
- 2007-01-11
- Last updated
- 2026-03-16
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00420563. Inclusion in this directory is not an endorsement.